Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/17/2003EP1370640A1 Lactic acid bacteria as agents for treating and preventing allergy
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/17/2003EP1370573A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370554A1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370544A1 Nitric oxide donors based on metallic centres
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370529A1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370518A2 Tryptase-inhibitors
12/17/2003EP1370298A1 Elongated and multiple spacers in activatible prodrugs
12/17/2003EP1370293A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
12/17/2003EP1370290A2 Molecular antigen array
12/17/2003EP1370277A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370274A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases
12/17/2003EP1370271A2 A process for the manufacture of a herbal composition comprising a matrine
12/17/2003EP1370264A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
12/17/2003EP1370261A2 New use
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1370249A1 Novel dendriticpolymers and their biomedical uses
12/17/2003EP1370241A1 Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same
12/17/2003EP1370239A1 New composition
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1319010B1 Tricyclic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (mmp) inhibitors
12/17/2003EP1263425B1 Use of comt inhibitors as analgesics
12/17/2003EP1246825B1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP0984981B1 Anti-inflammatory tyrosine derivatives
12/17/2003EP0900212B1 Chiral phenyldihydrofuranones as pde-iv inhibitors
12/17/2003EP0554291B1 Treatment of non-inflammatory bowel disorders
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462187A Analgesic/antiinflammatary patches for topical use
12/17/2003CN1461642A Method for prepn. of clathrate of keto-brufen and beta-cydodextrin or its derivatives
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131072C Radioactive chitosan complex, its preparation method and use
12/17/2003CN1131066C Application of radix scutellariae stem and leaf for preparing medicine for analgesia, anti-flammatory/and antipyretic
12/17/2003CN1131065C Medicine for treating hemipara lysis, obstruction of qi in the chest and cardialgia
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/16/2003US6664406 Fatty acid esters used as antiinflammatory or immunomodulatory agents
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664256 Interleukin- 1 beta inhibitors
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003US6663864 Crohn's disease, tumor necrosis factor, interleukins
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101490A1 Drug composition containing calcium channel antagonist
12/11/2003WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003WO2003101464A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003101217A1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003084984A8 Heterocyclic amides with alpha-4 integrin antagonist activity
1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 1272